3. Public hearings
1. Public hearings
Public hearings are a tool allowing the EMA to engage with European Union (EU) citizens in the supervision of medicines and listen to their views and experiences.
The EU's pharmacovigilance legislation enables the PRAC to hold public hearings during certain safety reviews of medicines. They support the committee's decision-making by providing perspectives, knowledge and insights into the way medicines are used.